Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center

This study was designed to determine the enrollment patterns in breast cancer clinical trials (CCTs) of patients with diverse backgrounds in an equal access setting and to evaluate the factors contributing to low rates of clinical trial accrual in patients of low socioeconomic status (SES). We perfo...

Full description

Saved in:
Bibliographic Details
Published in:NPJ breast cancer 2024-08, Vol.10 (1), p.70-5, Article 70
Main Authors: Podany, Emily L., Bulsara, Shaun, Sanchez, Katherine, Otte, Kristen, Ellis, Matthew J., Kinik, Maryam
Format: Article
Language:English
Subjects:
692/4028/67/1347
692/700/478
Biomedical and Life Sciences
Biomedicine
Breast cancer
Cancer Research
Cell Biology
Clinical trials
Human Genetics
Oncology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c422t-f23f13e06f067639a4401c97baecc0e438490966976ebc96ee1295ff92e95aa73
container_end_page 5
container_issue 1
container_start_page 70
container_title NPJ breast cancer
container_volume 10
creator Podany, Emily L.
Bulsara, Shaun
Sanchez, Katherine
Otte, Kristen
Ellis, Matthew J.
Kinik, Maryam
description This study was designed to determine the enrollment patterns in breast cancer clinical trials (CCTs) of patients with diverse backgrounds in an equal access setting and to evaluate the factors contributing to low rates of clinical trial accrual in patients of low socioeconomic status (SES). We performed a retrospective review of a prospectively maintained database of new patients seen at the Dan L. Duncan Comprehensive Cancer Center dating from 5/2015 to 9/2021, which included 3043 patients screened for breast CCTs. We compared the rate of CCT availability, eligibility, and enrollment between two patient populations: Smith Clinic, where most patients are of low SES and uninsured, and Baylor St. Luke’s Medical Center (BSLMC) with mostly predominantly insured, higher income patients. We performed logistic regression to evaluate whether differences in age, clinic, race, trial type, and primary language may be underlying the differences in CCT enrollment. More patients were eligible for CCTs at Smith Clinic (53.7% vs 44.7%, p  
doi_str_mv 10.1038/s41523-024-00672-0
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9a5b28e836a2471e9aa140bc57dd0d80</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9a5b28e836a2471e9aa140bc57dd0d80</doaj_id><sourcerecordid>3087617351</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-f23f13e06f067639a4401c97baecc0e438490966976ebc96ee1295ff92e95aa73</originalsourceid><addsrcrecordid>eNp9kk1v1DAQhiMEolXpH-CAInHhEhh_xI5PCCo-KlXiAmdr4ky2XiX2Ymcr8e_xbsrScuBiWzOvH89rvVX1ksFbBqJ7lyVruWiAywZAad7Ak-qcCy0bqbR--uB8Vl3mvAUAJlVnWva8OhMGjG61Oq_6j4kwL7XD4CjVbvLBO5zqJfmy7jAt3vkdLj6GGucYNvXg7yhlqg9FCkuucamxdnHeJbqlkEv7RCt9Si-qZyNOmS7v94vqx-dP36--NjffvlxffbhpnOR8aUYuRiYI1FjsKGFQSmDO6B7JOSApOlmmVspoRb0ziohx046j4WRaRC0uquuVO0Tc2l3yM6ZfNqK3x0JMG3u0M5E12Pa8o04o5FIzMohMQu9aPQwwdFBY71fWbt_PNByMJJweQR93gr-1m3hnWRlKG-gK4c09IcWfe8qLnX12NE0YKO6zFdBpZYxUqkhf_yPdxn0K5a9WFdOiZUXFV5VLMedE42kaBvYQCbtGwpZI2GMk7MHHq4c-Tlf-BKAIxCrIpRU2lP6-_R_sb7Ljwio</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3087617351</pqid></control><display><type>article</type><title>Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center</title><source>Publicly Available Content Database</source><source>PubMed</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Podany, Emily L. ; Bulsara, Shaun ; Sanchez, Katherine ; Otte, Kristen ; Ellis, Matthew J. ; Kinik, Maryam</creator><creatorcontrib>Podany, Emily L. ; Bulsara, Shaun ; Sanchez, Katherine ; Otte, Kristen ; Ellis, Matthew J. ; Kinik, Maryam</creatorcontrib><description>This study was designed to determine the enrollment patterns in breast cancer clinical trials (CCTs) of patients with diverse backgrounds in an equal access setting and to evaluate the factors contributing to low rates of clinical trial accrual in patients of low socioeconomic status (SES). We performed a retrospective review of a prospectively maintained database of new patients seen at the Dan L. Duncan Comprehensive Cancer Center dating from 5/2015 to 9/2021, which included 3043 patients screened for breast CCTs. We compared the rate of CCT availability, eligibility, and enrollment between two patient populations: Smith Clinic, where most patients are of low SES and uninsured, and Baylor St. Luke’s Medical Center (BSLMC) with mostly predominantly insured, higher income patients. We performed logistic regression to evaluate whether differences in age, clinic, race, trial type, and primary language may be underlying the differences in CCT enrollment. More patients were eligible for CCTs at Smith Clinic (53.7% vs 44.7%, p  &lt; 0.001). However, Smith Clinic patients were more likely to decline CCT enrollment compared to BSLMC (61.3% declined vs 39.4%, p  &lt; 0.001). On multivariate analysis, Black patients had a significantly higher rate of CCT refusal overall (OR = 0.26, 95% CI 0.12–0.56, p  &lt; 0.001) and BSLMC only (OR = 0.20, 95% CI 0.060–0.60, p  = 0.006). Our data shows that it is likely an oversimplification to assume that equal access will lead to the elimination of CCT disparities. Efforts to diversify CCTs must include consideration of structural and institutional inequities as well as social needs.</description><identifier>ISSN: 2374-4677</identifier><identifier>EISSN: 2374-4677</identifier><identifier>DOI: 10.1038/s41523-024-00672-0</identifier><identifier>PMID: 39097576</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/4028/67/1347 ; 692/700/478 ; Biomedical and Life Sciences ; Biomedicine ; Breast cancer ; Cancer Research ; Cell Biology ; Clinical trials ; Human Genetics ; Oncology</subject><ispartof>NPJ breast cancer, 2024-08, Vol.10 (1), p.70-5, Article 70</ispartof><rights>The Author(s) 2024</rights><rights>2024. The Author(s).</rights><rights>The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c422t-f23f13e06f067639a4401c97baecc0e438490966976ebc96ee1295ff92e95aa73</cites><orcidid>0000-0002-9700-3616</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/3087617351/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3087617351?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39097576$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Podany, Emily L.</creatorcontrib><creatorcontrib>Bulsara, Shaun</creatorcontrib><creatorcontrib>Sanchez, Katherine</creatorcontrib><creatorcontrib>Otte, Kristen</creatorcontrib><creatorcontrib>Ellis, Matthew J.</creatorcontrib><creatorcontrib>Kinik, Maryam</creatorcontrib><title>Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center</title><title>NPJ breast cancer</title><addtitle>npj Breast Cancer</addtitle><addtitle>NPJ Breast Cancer</addtitle><description>This study was designed to determine the enrollment patterns in breast cancer clinical trials (CCTs) of patients with diverse backgrounds in an equal access setting and to evaluate the factors contributing to low rates of clinical trial accrual in patients of low socioeconomic status (SES). We performed a retrospective review of a prospectively maintained database of new patients seen at the Dan L. Duncan Comprehensive Cancer Center dating from 5/2015 to 9/2021, which included 3043 patients screened for breast CCTs. We compared the rate of CCT availability, eligibility, and enrollment between two patient populations: Smith Clinic, where most patients are of low SES and uninsured, and Baylor St. Luke’s Medical Center (BSLMC) with mostly predominantly insured, higher income patients. We performed logistic regression to evaluate whether differences in age, clinic, race, trial type, and primary language may be underlying the differences in CCT enrollment. More patients were eligible for CCTs at Smith Clinic (53.7% vs 44.7%, p  &lt; 0.001). However, Smith Clinic patients were more likely to decline CCT enrollment compared to BSLMC (61.3% declined vs 39.4%, p  &lt; 0.001). On multivariate analysis, Black patients had a significantly higher rate of CCT refusal overall (OR = 0.26, 95% CI 0.12–0.56, p  &lt; 0.001) and BSLMC only (OR = 0.20, 95% CI 0.060–0.60, p  = 0.006). Our data shows that it is likely an oversimplification to assume that equal access will lead to the elimination of CCT disparities. Efforts to diversify CCTs must include consideration of structural and institutional inequities as well as social needs.</description><subject>692/4028/67/1347</subject><subject>692/700/478</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Breast cancer</subject><subject>Cancer Research</subject><subject>Cell Biology</subject><subject>Clinical trials</subject><subject>Human Genetics</subject><subject>Oncology</subject><issn>2374-4677</issn><issn>2374-4677</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kk1v1DAQhiMEolXpH-CAInHhEhh_xI5PCCo-KlXiAmdr4ky2XiX2Ymcr8e_xbsrScuBiWzOvH89rvVX1ksFbBqJ7lyVruWiAywZAad7Ak-qcCy0bqbR--uB8Vl3mvAUAJlVnWva8OhMGjG61Oq_6j4kwL7XD4CjVbvLBO5zqJfmy7jAt3vkdLj6GGucYNvXg7yhlqg9FCkuucamxdnHeJbqlkEv7RCt9Si-qZyNOmS7v94vqx-dP36--NjffvlxffbhpnOR8aUYuRiYI1FjsKGFQSmDO6B7JOSApOlmmVspoRb0ziohx046j4WRaRC0uquuVO0Tc2l3yM6ZfNqK3x0JMG3u0M5E12Pa8o04o5FIzMohMQu9aPQwwdFBY71fWbt_PNByMJJweQR93gr-1m3hnWRlKG-gK4c09IcWfe8qLnX12NE0YKO6zFdBpZYxUqkhf_yPdxn0K5a9WFdOiZUXFV5VLMedE42kaBvYQCbtGwpZI2GMk7MHHq4c-Tlf-BKAIxCrIpRU2lP6-_R_sb7Ljwio</recordid><startdate>20240803</startdate><enddate>20240803</enddate><creator>Podany, Emily L.</creator><creator>Bulsara, Shaun</creator><creator>Sanchez, Katherine</creator><creator>Otte, Kristen</creator><creator>Ellis, Matthew J.</creator><creator>Kinik, Maryam</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><general>Nature Portfolio</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-9700-3616</orcidid></search><sort><creationdate>20240803</creationdate><title>Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center</title><author>Podany, Emily L. ; Bulsara, Shaun ; Sanchez, Katherine ; Otte, Kristen ; Ellis, Matthew J. ; Kinik, Maryam</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-f23f13e06f067639a4401c97baecc0e438490966976ebc96ee1295ff92e95aa73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>692/4028/67/1347</topic><topic>692/700/478</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Breast cancer</topic><topic>Cancer Research</topic><topic>Cell Biology</topic><topic>Clinical trials</topic><topic>Human Genetics</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Podany, Emily L.</creatorcontrib><creatorcontrib>Bulsara, Shaun</creatorcontrib><creatorcontrib>Sanchez, Katherine</creatorcontrib><creatorcontrib>Otte, Kristen</creatorcontrib><creatorcontrib>Ellis, Matthew J.</creatorcontrib><creatorcontrib>Kinik, Maryam</creatorcontrib><collection>SpringerOpen</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>NPJ breast cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Podany, Emily L.</au><au>Bulsara, Shaun</au><au>Sanchez, Katherine</au><au>Otte, Kristen</au><au>Ellis, Matthew J.</au><au>Kinik, Maryam</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center</atitle><jtitle>NPJ breast cancer</jtitle><stitle>npj Breast Cancer</stitle><addtitle>NPJ Breast Cancer</addtitle><date>2024-08-03</date><risdate>2024</risdate><volume>10</volume><issue>1</issue><spage>70</spage><epage>5</epage><pages>70-5</pages><artnum>70</artnum><issn>2374-4677</issn><eissn>2374-4677</eissn><abstract>This study was designed to determine the enrollment patterns in breast cancer clinical trials (CCTs) of patients with diverse backgrounds in an equal access setting and to evaluate the factors contributing to low rates of clinical trial accrual in patients of low socioeconomic status (SES). We performed a retrospective review of a prospectively maintained database of new patients seen at the Dan L. Duncan Comprehensive Cancer Center dating from 5/2015 to 9/2021, which included 3043 patients screened for breast CCTs. We compared the rate of CCT availability, eligibility, and enrollment between two patient populations: Smith Clinic, where most patients are of low SES and uninsured, and Baylor St. Luke’s Medical Center (BSLMC) with mostly predominantly insured, higher income patients. We performed logistic regression to evaluate whether differences in age, clinic, race, trial type, and primary language may be underlying the differences in CCT enrollment. More patients were eligible for CCTs at Smith Clinic (53.7% vs 44.7%, p  &lt; 0.001). However, Smith Clinic patients were more likely to decline CCT enrollment compared to BSLMC (61.3% declined vs 39.4%, p  &lt; 0.001). On multivariate analysis, Black patients had a significantly higher rate of CCT refusal overall (OR = 0.26, 95% CI 0.12–0.56, p  &lt; 0.001) and BSLMC only (OR = 0.20, 95% CI 0.060–0.60, p  = 0.006). Our data shows that it is likely an oversimplification to assume that equal access will lead to the elimination of CCT disparities. Efforts to diversify CCTs must include consideration of structural and institutional inequities as well as social needs.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>39097576</pmid><doi>10.1038/s41523-024-00672-0</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-9700-3616</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2374-4677
ispartof NPJ breast cancer, 2024-08, Vol.10 (1), p.70-5, Article 70
issn 2374-4677
2374-4677
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9a5b28e836a2471e9aa140bc57dd0d80
source Publicly Available Content Database; PubMed; Springer Nature - nature.com Journals - Fully Open Access
subjects 692/4028/67/1347
692/700/478
Biomedical and Life Sciences
Biomedicine
Breast cancer
Cancer Research
Cell Biology
Clinical trials
Human Genetics
Oncology
title Breast cancer clinical trial participation among diverse patients at a comprehensive cancer center
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T18%3A50%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Breast%20cancer%20clinical%20trial%20participation%20among%20diverse%20patients%20at%20a%20comprehensive%20cancer%20center&rft.jtitle=NPJ%20breast%20cancer&rft.au=Podany,%20Emily%20L.&rft.date=2024-08-03&rft.volume=10&rft.issue=1&rft.spage=70&rft.epage=5&rft.pages=70-5&rft.artnum=70&rft.issn=2374-4677&rft.eissn=2374-4677&rft_id=info:doi/10.1038/s41523-024-00672-0&rft_dat=%3Cproquest_doaj_%3E3087617351%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c422t-f23f13e06f067639a4401c97baecc0e438490966976ebc96ee1295ff92e95aa73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3087617351&rft_id=info:pmid/39097576&rfr_iscdi=true